Wegovy is the first GLP-1 medication for weight loss to gain approval from the Food and Drug Administration (FDA). The organization approved it in 2021. However, there are strict eligibility ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Sold under brand names including Wegovy and Ozempic, semaglutide works by mimicking a gut hormone called glucagon-like peptide-1 (GLP-1), hence the technical term for it is a GLP-1 receptor agonist.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

If you’ve been hearing a lot about GLP-1 receptor agonists like semaglutide, you’re not alone. The popularity of semaglutide, the active ingredient in Ozempic and Wegovy, has skyrocketed in ...